VarCov Co’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$436K Buy
+59,672
New +$563K 0.21% 162
2026
Q2
– Sell
-39,173
Closed -$435K – 507
2026
Q1
$435K Sell
39,173
-47,586
-55% -$601K 0.16% 237
2025
Q4
$1.44M Buy
+86,759
New +$1.24M 0.57% 26

Other funds holding PHAT

VarCov Co's PHAT Position: Q3 2026 in Review

VarCov Co opened a new position in Phathom Pharmaceuticals (PHAT) in Q3 2026: 59,672 shares worth $436K. The stake represents 0.21% of the portfolio and ranks #162 among its holdings. This is a return to the name: VarCov Co previously reported a position in PHAT as recently as Q1 2026.

VarCov Co first reported a position in PHAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q4 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • VarCov Co held 59,672 shares of Phathom Pharmaceuticals worth $436K as of Q3 2026.
  • Phathom Pharmaceuticals was a new VarCov Co position in Q3 2026.
  • Phathom Pharmaceuticals made up 0.21% of VarCov Co's portfolio in Q3 2026, its #162 holding.
  • VarCov Co first reported a position in Phathom Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • VarCov Co's Phathom Pharmaceuticals position peaked at $1.44M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.